NCT03817346View on ClinicalTrials.gov

Study of Ascending Single Oral Dose of GT-002 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 17, 2018

Primary Completion Date

March 31, 2019

Study Completion Date

May 31, 2019

Conditions
Safety and Tolerability
Interventions
DRUG

GT-002

Single ascending dose

DRUG

Placebo oral capsule

Comparator single ascending dose

Trial Locations (1)

20520

CRST Oy, Clinical Research Services Turku, Turku

Sponsors

Lead Sponsor

Gabather AB
All Listed Sponsors
collaborator

Smerud Medical Research International AS

OTHER

lead

Gabather AB

INDUSTRY